A survey of inclusion of the time element when reporting adverse effects in randomised controlled trials of cyclo-oxygenase-2 and tumour necrosis factor alpha inhibitors

Abstract

Background: The adequacy of reporting the time element in adverse effects in articles on randomised clinical trials of cyclooxygenase-2 and tumour necrosis factor (TNF) a antagonists was surveyed.